Based on our findings and current understanding of IIH pathophysiology, optimal candidates include patients with inadequate response to first-line treatments and those with significant metabolic dysfunction [4, 5, 14, 18]
If you are planning to start tirzepatide by a specific date, account for potential delays and order with buffer time
Date, dose, injection site, any side effects
Liraglutide injection : Still in shortage, with the manufacturer reporting two presentations available and three with limited availability
In clinical studies, the average weight loss was 15% and 20% with 77% of patients seeing sustained results for 2 years* *In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)